Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Anatara Lifesciences Ltd

INVESTOR PRESENTATION - Anatara Lifesciences Ltd

ASX:ANR

Anatara Lifesciences Ltd

Health

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.

Read more

Market Cap

$13.03m

Price at Close

$0.185

4w avg. Volume

52.63k

4w avg. Turnover

$9.18k

Announcements
announcementt+2 movementdate
  • Buy-back of Unmarketable Parcels of Shares

    Issued Capital

  • -10.53%

    14 Dec 2020

-10.53%

14 Dec 2020
  • Anatara Human Health Update

    Progress Report

  • 0.00%

    07 Dec 2020

0.00%

07 Dec 2020
  • Change of Director's Interest Notice

    Shareholder Details

  • 0.00%

    03 Dec 2020

0.00%

03 Dec 2020
  • Cleansing Notice

    Issued Capital

  • 0.00%

    03 Dec 2020

0.00%

03 Dec 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    03 Dec 2020

0.00%

03 Dec 2020
  • Appendix 3G

    Issued Capital

  • 0.00%

    03 Dec 2020

0.00%

03 Dec 2020
  • Appendix 2A

    Issued Capital

  • 0.00%

    03 Dec 2020

0.00%

03 Dec 2020
  • Final Director's Interest Notice

    Shareholder Details

  • -5.13%

    29 Nov 2020

-5.13%

29 Nov 2020
  • Amended Constitution

    Company Administration

  • 0.00%

    26 Nov 2020

0.00%

26 Nov 2020
  • Results of Meeting

    Notice Of Meeting

  • 0.00%

    26 Nov 2020

0.00%

26 Nov 2020
Market Data

Current Price

$0.185

52WK HIGH

$0.45

52WK LOW

$0.13

1YR RETURN

-37.29%

1YR RETURN VS. SECTOR

-74.80%

90 DAY RETURN

-7.50%

ASX RANK

1,709

/2,047

SECTOR RANK

156

/168

SHARES OUTSTANDING

70.45m
ASX:ANR

Anatara Lifesciences Ltd

Health

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.

Read more

Market Cap

$13.03m

Price at Close

$0.185

4w avg. Volume

52.63k

4w avg. Turnover

$9.18k

ASX:ANR is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.